다우존스 지수

실시간 알림, 사용자 정의 포트폴리오 및 시장 동향을 받으려면 등록하세요.

등록

홈
인베스팅
주식
미국
NASDAQ
Adamas Pharmaceuticals Inc (ADMS)
Adamas Pharmaceuticals Inc (ADMS) 뉴스

ADMS

Adamas Pharmaceuticals (ADMS)

Adamas Pharmaceuticals Inc

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:ADMS

1 2 3 4 5 6 7 8 9 10 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2022/02/15	20:35	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:ADMS	Adamas Pharmaceuticals Inc
2022/01/27	01:01	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:ADMS	Adamas Pharmaceuticals Inc
2021/12/10	22:53	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:ADMS	Adamas Pharmaceuticals Inc
2021/12/02	20:15	Edgar (US Regulatory)	Notice of Effectiveness (effect)	NASDAQ:ADMS	Adamas Pharmaceuticals Inc
2021/11/25	06:12	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:ADMS	Adamas Pharmaceuticals Inc
2021/11/25	06:11	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:ADMS	Adamas Pharmaceuticals Inc
2021/11/25	06:11	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:ADMS	Adamas Pharmaceuticals Inc
2021/11/25	06:10	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:ADMS	Adamas Pharmaceuticals Inc
2021/11/25	06:08	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:ADMS	Adamas Pharmaceuticals Inc
2021/11/25	01:54	Edgar (US Regulatory)	Post-effective Amendment to an S-8 Filing (s-8 Pos)	NASDAQ:ADMS	Adamas Pharmaceuticals Inc
2021/11/25	01:47	Edgar (US Regulatory)	Post-effective Amendment to an S-8 Filing (s-8 Pos)	NASDAQ:ADMS	Adamas Pharmaceuticals Inc
2021/11/25	01:46	Edgar (US Regulatory)	Post-effective Amendment to an S-8 Filing (s-8 Pos)	NASDAQ:ADMS	Adamas Pharmaceuticals Inc
2021/11/25	01:43	Edgar (US Regulatory)	Post-effective Amendment to an S-8 Filing (s-8 Pos)	NASDAQ:ADMS	Adamas Pharmaceuticals Inc
2021/11/24	23:28	Edgar (US Regulatory)	Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or Retired Securities Initial Filing Amendments (25-nse)	NASDAQ:ADMS	Adamas Pharmaceuticals Inc
2021/11/24	23:18	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:ADMS	Adamas Pharmaceuticals Inc
2021/11/24	23:17	Edgar (US Regulatory)	Amended Statement of Ownership: Solicitation (sc 14d9/a)	NASDAQ:ADMS	Adamas Pharmaceuticals Inc
2021/11/24	23:12	GlobeNewswire Inc.	Supernus Pharmaceuticals Completes Acquisition of Adamas Pharmaceuticals	NASDAQ:ADMS	Adamas Pharmaceuticals Inc
2021/11/23	22:22	Edgar (US Regulatory)	Amended Tender Offer Statement by Third Party (sc To-t/a)	NASDAQ:ADMS	Adamas Pharmaceuticals Inc
2021/11/23	22:00	GlobeNewswire Inc.	Supernus Pharmaceuticals Announces Expiration of Hart-Scott-Rodino Waiting Period for Adamas Pharmaceuticals Tender Offer	NASDAQ:ADMS	Adamas Pharmaceuticals Inc
2021/11/23	20:05	Edgar (US Regulatory)	Amended Statement of Ownership: Solicitation (sc 14d9/a)	NASDAQ:ADMS	Adamas Pharmaceuticals Inc
2021/11/18	22:58	Edgar (US Regulatory)	Amended Statement of Ownership: Solicitation (sc 14d9/a)	NASDAQ:ADMS	Adamas Pharmaceuticals Inc
2021/11/11	06:03	Edgar (US Regulatory)	Quarterly Report (10-q)	NASDAQ:ADMS	Adamas Pharmaceuticals Inc
2021/11/02	05:55	Edgar (US Regulatory)	Written Communication by the Subject Company Relating to a Third Party Tender Offer (sc14d9c)	NASDAQ:ADMS	Adamas Pharmaceuticals Inc
2021/10/26	06:24	Edgar (US Regulatory)	Amended Statement of Ownership: Solicitation (sc 14d9/a)	NASDAQ:ADMS	Adamas Pharmaceuticals Inc
2021/10/26	00:26	Edgar (US Regulatory)	Statement of Ownership: Solicitation (sc 14d9)	NASDAQ:ADMS	Adamas Pharmaceuticals Inc
2021/10/25	23:22	Edgar (US Regulatory)	Tender Offer Statement by Third Party (sc To-t)	NASDAQ:ADMS	Adamas Pharmaceuticals Inc
2021/10/20	05:27	Edgar (US Regulatory)	Statement of Beneficial Ownership (sc 13d)	NASDAQ:ADMS	Adamas Pharmaceuticals Inc
2021/10/14	06:14	Edgar (US Regulatory)	Written Communication by the Subject Company Relating to a Third Party Tender Offer (sc14d9c)	NASDAQ:ADMS	Adamas Pharmaceuticals Inc
2021/10/12	20:56	Edgar (US Regulatory)	Written Communication Relating to an Issuer or Third Party (sc To-c)	NASDAQ:ADMS	Adamas Pharmaceuticals Inc
2021/10/12	20:05	Edgar (US Regulatory)	Statement of Ownership: Solicitation (sc 14d9)	NASDAQ:ADMS	Adamas Pharmaceuticals Inc

검색 관련기사 보기:NASDAQ:ADMS

1 2 3 4 5 6 7 8 9 10 다음 >>

WisdomTree Europe SmallC...

Exchange Traded Funds

Ebrd Tf 0,5% Nv25 Usd

Kfw Tf 1,5% Gn24 Eur

Webster Financial

Smart Ventures (CE)

Arval Service Lease Dome...

Vanguard S&P Mid Cap 400...

Delayed Upgrade Clock

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관